CAPTRUST Financial Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-439
Closed -$17K 4138
2022
Q2
$17K Hold
439
﹤0.01% 3467
2022
Q1
$21K Buy
439
+32
+8% +$1.65K ﹤0.01% 3363
2021
Q4
$30K Buy
407
+48
+13% +$3.94K ﹤0.01% 3029
2021
Q3
$33K Buy
359
+118
+49% +$10K ﹤0.01% 2851
2021
Q2
$15K Sell
241
-10
-4% -$370 ﹤0.01% 3322
2021
Q1
$7K Buy
+251
New +$6.04K ﹤0.01% 3613

Other funds holding ASTH

CAPTRUST Financial Advisors's ASTH Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Astrana Health (ASTH) in Q3 2022, closing a stake of 439 shares — an estimated $17K sold.

CAPTRUST Financial Advisors first reported a position in ASTH in Q1 2021 and held it in 6 quarters. The position peaked at $33K in Q3 2021. 154 funds tracked by Wall St. Rank hold ASTH as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Astrana Health position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 439 Astrana Health shares in Q3 2022, an estimated $17K.
  • CAPTRUST Financial Advisors first reported a position in Astrana Health in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Astrana Health position peaked at $33K in Q3 2021.
  • 154 funds tracked by Wall St. Rank held Astrana Health as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.